17 companies

Ascendis Pharma

Market Cap: US$14.2b

Operates as a biopharmaceutical company that focuses on developing TransCon-based therapies for unmet medical needs in Europe, the United States, and internationally.

ASND

US$228.06

7D

-5.2%

1Y

38.5%

Madrigal Pharmaceuticals

Market Cap: US$10.1b

A biopharmaceutical company, focuses on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH) in the United States.

New

MDGL

US$443.18

7D

2.4%

1Y

30.9%

Insmed

Market Cap: US$31.2b

Develops and commercializes therapies for patients with serious and rare diseases in the United States, Europe, Japan, and internationally.

INSM

US$143.93

7D

0.06%

1Y

86.9%

Alnylam Pharmaceuticals

Market Cap: US$42.3b

Alnylam Pharmaceuticals, Inc. discovers, develops, manufactures, and commercializes therapeutics based on ribonucleic acid interference in the United States, Europe, and internationally.

ALNY

US$320.42

7D

-0.6%

1Y

31.2%

BeOne Medicines

Market Cap: US$32.1b

An oncology company, engages in discovering and developing various treatments for cancer patients in the United States, China, Europe, and internationally.

ONC

US$287.33

7D

-5.9%

1Y

9.9%

BridgeBio Pharma

Market Cap: US$13.8b

A biopharmaceutical company, discovers, develops, and delivers medicines for patients with genetic diseases.

BBIO

US$70.94

7D

-4.5%

1Y

120.4%

Ionis Pharmaceuticals

Market Cap: US$11.9b

A commercial-stage biotechnology company, provides RNA-targeted medicines in the United States.

IONS

US$72.33

7D

-4.4%

1Y

119.5%

AbbVie

Market Cap: US$391.6b

A research-based biopharmaceutical company, engages in the research and development, manufacturing, commercializing, and sale of medicines and therapies worldwide.

ABBV

US$219.76

7D

-3.2%

1Y

2.8%

Jazz Pharmaceuticals

Market Cap: US$11.2b

Jazz Pharmaceuticals plc identifies, develops, and commercializes pharmaceutical products in the United States, Europe, and internationally.

JAZZ

US$181.37

7D

-2.5%

1Y

30.0%

Eli Lilly

Market Cap: US$883.6b

Eli Lilly and Company discovers, develops, manufactures, and markets human pharmaceutical products in the United States, Europe, China, Japan, and internationally.

LLY

US$930.35

7D

-7.1%

1Y

13.1%

BioMarin Pharmaceutical

Market Cap: US$11.0b

A biotechnology company, engages in the development and commercialization of therapies for life-threatening rare diseases and medical conditions in the United States, Europe, Latin America, the Middle East, the Asia Pacific, and internationally.

BMRN

US$56.05

7D

-7.9%

1Y

-21.6%

Natera

Market Cap: US$28.0b

A diagnostics company, engages in the development and commercialization of molecular testing services worldwide.

NTRA

US$198.38

7D

-0.3%

1Y

35.6%

Viatris

Market Cap: US$15.6b

Operates as a healthcare company in North America, Europe, China, Taiwan, Hong Kong, Japan, Australia, New Zealand, rest of Asia, Africa, Latin America, and the Middle East.

VTRS

US$13.80

7D

-2.0%

1Y

45.0%

Royalty Pharma

Market Cap: US$26.6b

Operates as a buyer of biopharmaceutical royalties and a funder of innovation in the biopharmaceutical industry in the United States.

RPRX

US$46.11

7D

0.3%

1Y

38.0%

Exact Sciences

Market Cap: US$19.8b

Provides cancer screening and diagnostic test products in the United States and internationally.

EXAS

US$103.94

7D

0.6%

1Y

131.4%

Elanco Animal Health

Market Cap: US$11.6b

An animal health company, innovates, develops, manufactures, and markets products for pets and farm animals worldwide.

ELAN

US$25.18

7D

6.4%

1Y

132.9%

Waters

Market Cap: US$28.5b

Provides analytical workflow solutions in Asia, the Americas, and Europe.

WAT

US$296.99

7D

-0.9%

1Y

-22.3%